Bristol-Myers Squibb Medical Imaging, Inc.

ABLAVAR

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; pharmaceutical preparations for use in increasing the heart rate;

ACERVANZ

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

ALTADENE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

BEZREZ

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

BRILPIC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

BRILVIZ

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

CARDIOKEYS

CARDIO KEYS;medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations and/or diagnostic imaging agents for human use;

CONVENIVENT

CONVENIENT VENT;Medical device used for obtaining access to contrast media vials and dispensing the contents of contrast media vials;

CORPICTA

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

DILAGENT

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; pharmaceutical preparations for use in increasing the heart rate;

EFFOSCI

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

EIDEFLO

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

EIDEVLO

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

ENVASCEND

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

ESCATEC

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

ESCAVAZE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

EVEREVE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; pharmaceutical preparations for use in increasing the heart rate;EVER EVE;

EXTENDENE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

EZAVAZE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

FACILACEP

Pharmaceutical prepartions for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

FYDRESO

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

HARMODENE

Pharmaceutical prepartions for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

INNOVATORS AT HEART

Pharmaceutical preparations, namely, diagnostic imaging and ultrasound contrast agents;

INTELLIVENT

INTELLIGENT VENT;Medical device used for obtaining access to contrast media vials and dispensing the contents of contrast media vials;

MI-VENT

MEDICAL IMAGING-VENT;Medical device used for obtaining access to contrast media vials and dispensing the contents of contrast media vials;

ONFIDA

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

ONVUSAV

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

PICTRA

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

PICTRU

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

PICTRUS

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

PORTRAIC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

READIVENT

READY VENT;Medical device used for obtaining access to contrast media vials and dispensing the contents of contrast media vials;

RECEPAA

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

REZAPEX

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

REZLARTA

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

REZLARTI

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

SCIARTO

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;

SCIPIFIC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

SCYPIFIC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for indentifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations that increase the heart rate for diagnostic purposes;

SELECTADENE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

SOLOVENT

SOLO VENT;Medical device used for obtaining access to contrast media vials and dispensing the contents of contrast media vials;

SPANTRIA

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; pharmaceutical preparations for use in increasing the heart rate;

VALTAVAZE

Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions;

VIZLUMIC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

VIZLUMIV

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes;

ZYSIV

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents;